Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (symbol: PHR) is a leading provider of comprehensive software solutions designed to enhance the operational and financial performance of healthcare organizations. Through its innovative SaaS-based technology platform, Phreesia enables medical groups of all sizes to streamline their administrative, financial, and clinical operations, thereby allowing healthcare staff to focus more on delivering exceptional patient care.
The Phreesia Platform offers a robust suite of integrated solutions that manage various aspects of patient interactions. These solutions include patient access, registration, payments, and clinical support, all aimed at optimizing patient health outcomes. By activating patients in their care, Phreesia ensures that healthcare providers can offer more personalized and efficient services.
Phreesia's flexible and scalable platform is trusted by leading healthcare organizations to revolutionize their point of service. The platform encompasses a wide range of technologies and services, from initial patient contact and registration to appointment scheduling, payment processing, and post-appointment patient surveys. This comprehensive range of services drives tangible results, enhancing both patient and provider experiences.
Recent achievements and current projects at Phreesia include continuous updates to their software to ensure compatibility with the latest technological advancements and regulatory requirements. The company also focuses on forming strategic partnerships that further enhance the capabilities of their platform.
In terms of financial condition, Phreesia has shown consistent growth, driven by the increasing demand for efficient healthcare management solutions. The company's ability to adapt to the evolving needs of the healthcare industry makes it a significant player in the market.
Phreesia, Inc. (NYSE: PHR) reported financial results for Q4 and FY 2022, emphasizing a strong revenue growth of 39% year-over-year to $58.0 million in Q4, and 43% growth to $213.2 million for the fiscal year. Despite increased revenues, Adjusted EBITDA was negative $30.5 million for Q4 and negative $59.0 million for the full year. Cash reserves stood at $313.8 million. Looking ahead, the company forecasts FY 2023 revenue between $271 million and $275 million, indicating a growth of 27% to 29%, but expects Adjusted EBITDA to worsen before recovering in FY 2025.
Phreesia, Inc. (NYSE: PHR) will host a conference call on March 30, 2022, at 5:00 p.m. ET to discuss its fiscal fourth quarter 2022 financial results. A press release detailing these results will be issued before the call, following market close on the same day. The company provides a suite of applications to enhance patient intake processes through its innovative SaaS platform, improving patient engagement and clinical care efficiency.
Phreesia (NYSE: PHR) has been named the 2022 Best in KLAS for Patient Intake Management for the fourth consecutive year, highlighting its excellence in healthcare IT services. The award, based on feedback from healthcare providers, recognizes Phreesia's robust platform that automates patient outreach and intake processes, including self-service registration and insurance verification. Phreesia earned a top score of 90.0, demonstrating its commitment to enhance clinical care and efficiency. CEO Chaim Indig emphasized ongoing investment in their platform to support healthcare providers.
Phreesia has joined MEDITECH Greenfield, a pilot program aimed at fostering app integration with MEDITECH Expanse. This collaboration will enhance patient engagement in their care by enabling API-based integration, notifying patients about preventive care gaps, and reducing barriers to access. CEO Chaim Indig emphasized the importance of interoperability in healthcare, stating this partnership will support the development of innovative solutions for MEDITECH clients. The initiative aims to set an industry standard for interoperability.
Phreesia, listed on NYSE as PHR, has received recognition from PM360, a healthcare marketing publication, for its PatientInsights platform, which was named one of the 2021 Most Innovative Services. This honor reflects PatientInsights' effectiveness in conducting targeted patient surveys before doctor appointments, yielding higher completion rates and reliable data. The platform's integration with electronic health records streamlines survey processes, significantly reducing question counts. Phreesia continues to position itself at the forefront of patient-centric healthcare solutions.
Phreesia has been recognized by Medical Marketing and Media (MM+M) as one of the Best Places to Work 2021 in the healthcare marketing industry. This marks the fourth year of the awards, where Phreesia was highlighted in the 'Large Companies/Service Providers' category, being one of only two companies to receive this honor. Employees praised the company's inclusive culture and benefits, especially its response to COVID-19, which included enhanced pay and support for remote work. The recognition underscores Phreesia's commitment to transforming the patient experience.
Phreesia has acquired Insignia Health, LLC, a company focused on improving health outcomes through patient activation. This acquisition enhances Phreesia's mission to empower patients in their healthcare journey. Insignia holds the exclusive license for the Patient Activation Measure® (PAM®), recognized as the gold standard for assessing patient activation. The integration is expected to broaden PAM's reach, improving patient engagement and outcomes. Phreesia aims to leverage Insignia's expertise to provide more personalized care.
Phreesia, Inc. (NYSE: PHR) reported a strong fiscal third quarter ended October 31, 2021, with revenue reaching $55.9 million, a 45% increase year-over-year. The average number of provider clients grew by 21% to 2,097, with average revenue per client increasing by 10% to $19,299. Despite these positive metrics, the adjusted EBITDA was negative $17.6 million, reflecting increased investment. The company raised its revenue outlook for FY 2022 to $211 million and expects further growth of 20-25% in FY 2023.
Phreesia (NYSE: PHR) will host a conference call on December 9, 2021, at 8:45 a.m. ET to discuss its fiscal third quarter 2022 financial results. The financial results will be announced following market close on December 8, 2021. Phreesia provides healthcare organizations with a comprehensive suite of applications designed to improve the patient intake process, enhancing patient engagement and operational efficiency.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
What does Phreesia, Inc. do?
What is the Phreesia Platform?
How does Phreesia benefit healthcare organizations?
What are some of Phreesia's recent achievements?
What makes Phreesia's platform scalable and flexible?
Who uses Phreesia's services?
What is Phreesia's approach to patient activation?
How does Phreesia enhance patient-provider interactions?
What are some key features of the Phreesia Platform?
How is Phreesia performing financially?
